Dear BloFin users,
We are pleased to announce that USDT-Margined perpetual contracts for $NEIRO and $XNO will be listed at 10:00 (UTC) on October 08, 2024.
The updates will cover both the web and app interfaces. The details are as follows:
-
NEIROUSDT and XNOUSDT Perpetual:
|
Feature
|
Details
|
Details
|
|---|---|---|
|
Underlying Asset
|
NEIRO (First Neiro On Ethereum)
|
XNO (NANO)
|
|
Settlement Asset
|
USDT
|
USDT
|
|
Contract Size
|
1000 NEIRO
|
10 XNO
|
|
Price Quotation
|
1000 NEIRO value calculated
in USDT equivalent
|
10 XNO value calculated in USDT equivalent
|
|
Tick Size
|
0.0000001
|
0.0001
|
|
Leverage
|
1-75x
|
1-12x
|
|
Funding Fee Settlement Frequency
|
Every 4 hours
|
Every 8 hours
|
|
Trading Hours
|
24/7
|
24/7
|
The price limit rules of NEIROUSDT and XNOUSDT perpetual trading are the same as those of other currencies. Please refer to our Trading Guides for further details.
Event: Trade NEIROUSDT and XNOUSDT with 0 Maker Fees & 50% off Taker Fees
To celebrate the listing of NEIROUSDT and XNOUSDT trading pairs on BloFin Futures, BloFin offers 0 Maker fees and 50% off Taker fees event for the first 48 hours for users when trading them, with Taker fees as low as 0.03%!
To experience the innovative power of BloFin, please go to the BloFin website or download the app from the Apple App Store and Google Play Store to trade easily on the go.
Thanks for your support!
BloFin Team
Oct 08, 2024
Find us on:
BloFin reserves the right, in its sole discretion, to amend or cancel this announcement at any time and for any reason without prior notice.
Risk Warning: Digital assets are highly speculative and subject to significant volatility. They may become illiquid at any time, and investors could lose the entire value of their investment. Before trading any digital asset, you should conduct your own research and assess your risk tolerance. BloFin is not liable for any losses you may incur from trading digital assets. This material should not be construed as financial advice. For more information, view our Terms of Use and Risk Warning.